Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1920 (LINC01920) is a member of the long intergenic non-coding RNA (lincRNA) family, characterized by transcripts longer than 200 nucleotides that do not encode proteins and are located in genomic regions that do not overlap with protein-coding genes. lincRNAs, including LINC01920, are believed to participate in the regulation of gene expression through diverse mechanisms, such as modification of chromatin states, interaction with RNA-binding proteins, and modulation of transcription. The individual biological function of LINC01920 remains uncharacterized at this time, and there are currently no established drugs that target this molecule, nor is there evidence that it serves as a therapeutic target or clinical biomarker. In general, lincRNAs as a class have been implicated in tissue-specific regulation and disease, including cancer, and are under active research for potential roles in tumor biology and as molecular biomarkers for diagnosis and therapy monitoring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1920 (LINC01920).